The 30-day rate of death or nonfatal MI in women was reduced by enoxaparin compared with unfractionated heparin in women (15.4% ersus 18.3%; P=0.007).

• 30天死亡率或者非致命性心肌梗死发生率在应用依诺肝素的女性患者低于应用普通肝素者（15.；4%25对18